Corflow Therapeutics AG is a biotechnology company based in Baar, Switzerland, specializing in the development of innovative therapeutic solutions for cardiovascular diseases. The company focuses on advancing its proprietary technologies aimed at improving patient outcomes through targeted drug delivery and enhanced treatment efficacy. With a commitment to addressing unmet medical needs, Corflow leverages its expertise in drug formulation and delivery systems to contribute to the evolving landscape of cardiovascular therapeutics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#29 in Baar

#983 in Switzerland

#51,761 in the World

Baar, Switzerland

Corflow Therapeutics Ag

Forward Citations = 39

10 inventors:

Robert S Schwartz (11 out of 162 patents)

Jon Helge Hoem (10 out of 17 patents)

Martin Terry Rothman (8 out of 48 patents)

4. Sabrina Frey (2 out of 2 patents)

5. Oliver Bludau (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Corflow Therapeutics Ag. Retrieved from https://idiyas.com/company/corflow-therapeutics-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]